X

Cytalux

FDA Agree To New Imaging Medicine To Assist Recognize Ovarian Cancer Lesions

The U.S. Food and Drug Administration today endorsed Cytalux (pafolacianine), an imaging drug expected to help specialists in distinguishing ovarian…

X

Headline

You can control the ways in which we improve and personalize your experience. Please choose whether you wish to allow the following:

Privacy Settings

All rights received